- --------------------------------------------------------------------------------

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                 --------------

                                    FORM 10-Q
(Mark One)
  X         QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
 ---              OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2001
                                       or
  ___   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                  SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission file number 1-11316

                                OMEGA HEALTHCARE
                                 INVESTORS, INC.
             (Exact name of Registrant as specified in its charter)

         Maryland                                     38-3041398
  (State of Incorporation)                (I.R.S. Employer Identification No.)

                 900 Victors Way, Suite 350, Ann Arbor, MI 48108
                    (Address of principal executive offices)

                                 (734) 887-0200
                     (Telephone number, including area code)

     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports) and (2) has been subject to such
filing requirements for the past 90 days.

Yes   X                                    No
    ------                                    -----

     Indicate the number of shares outstanding of each of the issuer's classes
of common stock as of March 31, 2001

   Common Stock, $.10 par value                               19,989,956
             (Class)                                      (Number of shares)


- --------------------------------------------------------------------------------








                        OMEGA HEALTHCARE INVESTORS, INC.

                                    FORM 10-Q

                                 March 31, 2001

                                      INDEX
                                                                                                Page No.
                                                                                                --------
                         
PART I   Financial Information

Item 1.           Condensed Consolidated Financial Statements:

                  Balance Sheets
                           March 31, 2001 (unaudited)
                           and December 31, 2000 ................................................. 2

                  Statements of Operations (unaudited)
                           Three-month period ended
                           March 31, 2001 and 2000 ............................................... 3

                  Statements of Cash Flows (unaudited)
                           Three-month period ended
                           March 31, 2001 and 2000 ............................................... 4

                  Notes to Condensed Consolidated Financial Statements
                           March 31, 2001 (unaudited) ............................................ 5

Item 2.           Management's Discussion and Analysis of
                           Financial Condition and Results of
                           Operations ............................................................19

Item 3.           Quantitative and Qualitative Disclosures About Market Risk .....................24

PART II. Other Information

Item 2.           Changes in Securities and Use of Proceeds ......................................25

Item 6.           Exhibits and Reports on Form 8-K ...............................................26






                          PART 1 - FINANCIAL INFORMATION

Item 1.      Financial Statements

                         OMEGA HEALTHCARE INVESTORS, INC.

                      CONDENSED CONSOLIDATED BALANCE SHEETS

                                  (In Thousands)
                                                                                                                     
                                                                                                March 31,              December 31,
                                                                                                  2001                     2000
                                                                                                  ----                     ----
                                                                                              (Unaudited)               (See Note)

                                      ASSETS
Real estate properties
     Land and buildings at cost ...............................................................$ 709,989                $ 710,542
     Less accumulated depreciation ............................................................  (94,151)                 (89,870)
                                                                                                 -------                 --------
             Real estate properties - net .....................................................  615,838                  620,672
     Mortgage notes receivable - net ..........................................................  206,774                  206,710
                                                                                                 -------                  -------
                                                                                                 822,612                  827,382
Other investments .............................................................................   53,224                   53,242
                                                                                                 -------                  -------
                                                                                                 875,836                  880,624
Assets held for sale - net ....................................................................    3,547                    4,013
                                                                                                 -------                  -------
     Total Investments ........................................................................  879,383                  884,637
Cash and cash equivalents .....................................................................    6,931                    7,172
Accounts receivable ...........................................................................   14,547                   10,497
Other assets ..................................................................................    7,903                    9,338
Operating assets for owned properties .........................................................   37,909                   36,807
                                                                                                --------                 --------
     Total Assets .............................................................................$ 946,673                $ 948,451
                                                                                               =========                =========

                       LIABILITIES AND SHAREHOLDERS' EQUITY
Revolving lines of credit .....................................................................$ 195,641                $ 185,641
Unsecured borrowings ..........................................................................  223,000                  225,000
Other long-term borrowings ....................................................................   23,973                   24,161
Subordinated convertible debentures ...........................................................        -                   16,590
Accrued expenses and other liabilities ........................................................   20,268                   18,002
Operating liabilities for owned properties ....................................................   15,314                   14,744
                                                                                                --------                 --------
     Total Liabilities ........................................................................  478,196                  484,138

Preferred Stock ...............................................................................  207,500                  207,500
Common stock and additional paid-in capital ...................................................  440,210                  440,556
Cumulative net earnings .......................................................................  187,041                  182,548
Cumulative dividends paid ..................................................................... (365,654)                (365,654)
Unamortized restricted stock awards ...........................................................     (236)                    (607)
Accumulated other comprehensive income (loss) .................................................     (384)                     (30)
                                                                                                --------                 --------
     Total Shareholders' Equity ...............................................................  468,477                  464,313
                                                                                                --------                 --------
     Total Liabilities and Shareholders' Equity ...............................................$ 946,673                $ 948,451
                                                                                               =========                =========

Note      - The balance sheet at December 31, 2000, has been derived from the
            audited consolidated financial statements at that date but does not
            include all of the information and footnotes required by generally
            accepted accounting principles for complete financial statements.

            See notes to condensed consolidated financial statements.






                                       2



                        OMEGA HEALTHCARE INVESTORS, INC.

                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                                    Unaudited
                    (In Thousands, Except Per Share Amounts)

                                                                           Three Months Ended
                                                                               March 31,
                                                                         ---------------------
                                                                           2001          2000
                                                                           ----          ----
                                                                                    
Revenues
  Rental income ........................................................$ 16,021      $ 18,002
  Mortgage interest income .............................................   5,678         6,000
  Other investment income - net ........................................   1,258         1,696
  Nursing home revenues of owned and operated assets ...................  45,997        31,425
  Miscellaneous ........................................................     223            91
                                                                          ------        ------
                                                                          69,177        57,214
Expenses
  Depreciation and amortization ........................................   5,541         5,910
  Interest .............................................................   9,672        11,098
  General and administrative ...........................................   2,349         1,589
  Legal ................................................................     951            21
  State taxes ..........................................................     106           113
  Provision for impairment .............................................       -         4,500
  Nursing home expenses of owned and operated assets ...................  46,450        30,965
  Charges for derivative accounting ....................................     482             -
                                                                          ------        ------
                                                                          65,551        54,196
                                                                          ------        ------

Earnings before gain on assets sold and gain on early
    extinguishment of debt .............................................   3,626         3,018
Gain on assets sold  - net .............................................     619             -
Gain on early extinguishment of debt ...................................     248             -
                                                                          ------        ------
Net earnings ...........................................................   4,493         3,018
Preferred stock dividends ..............................................  (4,908)       (2,408)
                                                                          ------        ------
Net(loss)earnings available to common .................................. $  (415)       $  610
                                                                           =====         =====

(Loss)Earnings per common share:
  Net(loss)earnings per share - basic .................................. $ (0.02)       $ 0.03
                                                                         =======        ======
  Net(loss)earnings per share - diluted ................................ $ (0.02)       $ 0.03
                                                                         =======        ======

Dividends declared and paid per common share ........................... $     -        $ 0.50
                                                                         =======        ======

Weighted Average Shares Outstanding, Basic .............................  20,013        19,982
                                                                          ======        ======
Weighted Average Shares Outstanding, Diluted ...........................  20,013        19,982
                                                                          ======        ======
Other comprehensive loss:
  Unrealized Loss on Omega Worldwide, Inc. ............................. $     -        $ (326)
                                                                          ======        ======
  Unrealized Loss on Hedging Contracts ..................................$  (354)       $    -
                                                                          ======        ======

Total comprehensive income ..............................................$ 4,139       $ 2,692
                                                                          ======        ======

           See notes to condensed consolidated financial statements.




                                       3





                        OMEGA HEALTHCARE INVESTORS, INC.
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                    Unaudited
                                 (In Thousands)

                                                                      Three Months Ended
                                                                            March 31,
                                                                      2001            2000
                                                                      ----            ----

                                                                                  
Operating activities
Net earnings ......................................................   $  4,493    $  3,018
Adjustment to reconcile net earnings to cash
provided by operating activities:
     Depreciation and amortization ................................      5,541       5,910
     Provision for impairment .....................................          -       4,500
     Provision for collection losses ..............................          -       1,437
     Gain on assets sold - net ....................................       (619)          -
     Gain on early extinguishment of debt .........................       (248)          -
     Other ........................................................        603         633
Net change in accounts receivable for Owned &
 Operated assets - net ............................................     (1,702)     (3,036)
Net change in accounts payable for Owned & Operated assets ........        359        (860)
Net change in other Owned & Operated assets and liabilities .......        811        (146)
Net change in operating assets and liabilities ....................      1,221       2,771
                                                                         -----       -----

Net cash provided by operating activities .........................     10,459      14,227

Cash flows from financing activities
Proceeds of revolving lines of credit - net .......................     10,000      10,400
Payments of long-term borrowings ..................................    (18,778)        (73)
Receipts from Dividend Reinvestment Plan ..........................          9         349
Dividends paid ....................................................          -     (12,408)
Deferred financing costs paid .....................................       (370)          -
Other .............................................................        (45)          -
                                                                          ----       -----
Net cash used in financing activities .............................     (9,184)     (1,732)

Cash flow from investing activities
Proceeds from sale of real estate investments - net ...............      1,230         230
Fundings of other investments - net ...............................     (3,167)    (14,709)
Collection of mortgage principal ..................................        421         388
                                                                           ---         ---
Net cash used in investing activities .............................     (1,516)    (14,091)
                                                                        ------     -------

Decrease in cash and cash equivalents .............................       (241)     (1,596)
Cash and cash equivalents at beginning of period ..................      7,172       4,105
                                                                         -----       -----
Cash and cash equivalents at end of period ........................   $  6,931    $  2,509
                                                                      ========    ========


            See notes to condensed consolidated financial statements.


                                       4



                        OMEGA HEALTHCARE INVESTORS, INC.

              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                   (UNAUDITED)

                                 March 31, 2001

Note A - Basis of Presentation

     The accompanying  unaudited condensed consolidated financial statements for
Omega  Healthcare  Investors,   Inc.  (the  "Company")  have  been  prepared  in
accordance with generally  accepted  accounting  principles in the United States
for interim  financial  information  and with the  instructions to Form 10-Q and
Article  10 of  Regulation  S-X.  Accordingly,  they do not  include  all of the
information and footnotes required by generally accepted  accounting  principles
for complete financial statements. In the opinion of management, all adjustments
(consisting of normal recurring accruals and impairment provisions to adjust the
carrying value of assets) considered necessary for a fair presentation have been
included.  Certain  reclassifications  have  been  made  to the  2000  financial
statements for consistency with the current presentation. Such reclassifications
have no effect on previously reported earnings or equity.  Operating results for
the three-month  period ended March 31, 2001 are not  necessarily  indicative of
the results  that may be expected for the year ending  December  31,  2001.  For
further  information,  refer to the financial  statements and footnotes  thereto
included in the Company's annual report on Form 10-K for the year ended December
31, 2000.


Note B - Properties

     In the ordinary course of its business activities, the Company periodically
evaluates  investment  opportunities  and extends  credit to customers.  It also
regularly engages in lease and loan extensions and modifications.  Additionally,
the Company  actively  monitors and manages its  investment  portfolio  with the
objectives of improving  credit  quality and increasing  returns.  In connection
with  portfolio  management,  the  Company  engages  in various  collection  and
foreclosure activities.

     When the Company  acquires  real estate  pursuant to a  foreclosure,  lease
termination  or bankruptcy  proceeding,  and does not  immediately  re-lease the
properties  to new  operators,  the assets are included on the balance  sheet as
"real estate  properties," and the value of such assets is reported at the lower
of cost or fair value.  (See "Owned and Operated  Assets" below).  Additionally,
when a formal plan to sell real estate is adopted, the real estate is classified
as "Assets Held for Sale," with the net carrying amount adjusted to the lower of
cost or fair value, less cost of disposal.

     Based  on  management's  current  review  of the  Company's  portfolio,  no
provision  was  recorded  for the  three-month  period  ended March 31,  2001. A
provision  for  impairment  in the  value  of the  Assets  Held for Sale of $4.5
million was recorded for the three-month period ended March 31, 2000.


                                       5



     A summary of the number of  properties  by category  for the quarter  ended
March 31, 2001 follows:



                                                                              Total
                                      Purchase                    Owned &   Healthcare       Held
                                      Leaseback     Mortgages     Operated  Facilities     For Sale     Total
                                      ---------     ---------     --------  ----------     --------     -----
                                                                                
Balance at December 31, 2000 ........    132            63           69         264            4         268
Properties transferred to
     Held for Sale ..................      -             -            -           -            -           -
Properties transferred to
    Owned & Operated ................      -             -            -           -            -           -
Properties Sold / Mortgages Paid ....      -            (4)          (3)         (7)          (1)         (8)
Properties Leased / Mortgages
    Placed ..........................      -             4            -           4            -           4
                                         ---           ---          ---         ---          ---         ---
Balance at March 31, 2001 ...........    132            63           66         261            3         264
                                         ===           ===          ===         ===          ===         ===




Real Estate Dispositions

     The Company disposed of four facilities during the three-month period ended
March 31,  2001.  Assets sold  consisted of three  facilities  in Indiana with a
total of 159 beds which were  classified  as Owned and Operated and one facility
in  Massachusetts  with 77 beds which was included in Assets Held for Sale.  The
Company  recognized a gain on the sale of the Owned and Operated  real estate in
the amount of $0.6 million. The Company provided  seller-financing in the amount
of $0.5 million for the property in Assets Held for Sale. The full amount of the
seller-financing  has been reserved and will be  recognized as collected.  Sales
proceeds generated from these sales totaled $1.2 million. During the three-month
period ended March 31, 2000, the Company realized  disposition  proceeds of $0.2
million from the sale of one facility.

Notes and Mortgages Receivable

     Income on notes and mortgages which are impaired will be recognized as cash
is received. No provision for loss on mortgages or notes receivable was recorded
during the three-month periods ended March 31, 2001 and 2000, respectively.

     Effective  February 1, 2001, four facilities  owned by Professional  Health
Care Management,  Inc. ("PHCM") a subsidiary of Mariner Post-Acute Network,  and
on which the  Company  held a first  mortgage  loan,  were sold to Midtown  Real
Estate Company, LLC ("Midtown").  PCHM loaned Midtown the entire purchase price,
and the Company assumed an undivided  fifty percent  interest in the acquisition
promissory  note.  The  Company's  fifty-percent  interest,  which  totals  $4.5
million, was credited against Mariner's  obligations to the Company. The term of
the loan with Midtown is 15 years, with an initial yield of 12.4%.


                                       6


Owned and Operated Assets

     The Company owns 66 facilities  that were  recovered from customers and are
operated for the Company's own account. These facilities have 5,079 beds and are
located in seven states.

     The Company  intends to operate these owned and operated assets for its own
account until such time as these  facilities'  operations are stabilized and are
re-leasable or saleable at lease rates or sale prices that maximize the value of
these  assets to the  Company.  Due to the  deterioration  in market  conditions
affecting  the long term care  industry,  the Company is unable to estimate when
such  re-leasing  and sales  objectives  might be  achieved  and now  intends to
operate such facilities for an extended  period.  As a result,  these facilities
and their  respective  operations are presented on a  consolidated  basis in the
Company's financial statements.

     The revenues,  expenses,  assets and liabilities  included in the Company's
condensed  consolidated  financial  statements  which  relate to such  owned and
operated assets are as follows:



                             (In Thousands)

                                                    Three Months Ended
                                                    ------------------
                                                  2001             2000
                                                  ----             ----
                                                               
Revenues (1)
Medicaid .................................... $ 27,240          $ 19,525
Medicare ....................................   11,190             6,755
Private & Other .............................    7,567             5,145
                                                 -----             -----
  Total Revenues ............................   45,997            31,425

Expenses
Patient Care Expenses .......................   33,153            22,374
Administration ..............................    6,535             4,679
Property & Related ..........................    3,214             2,295
                                                 -----             -----
  Total Expenses ............................   42,902            29,348

Contribution Margin .........................    3,095             2,077

Management Fees .............................    2,449             1,617
Rent ........................................    1,099                 -
                                                 -----             -----

EBITDA (2) .................................. $   (453)         $    460
                                              ========          ========





              (1) Nursing home revenues from these owned and operated assets are
                  recognized as services are provided.
              (2) EBITDA represents earnings before interest, income taxes,
                  depreciation and amortization. It is considered by the Company
                  to be a meaningful measure of performance of its owned and
                  operated assets. EBITDA in and of itself does not represent
                  cash generated from operating activities in accordance with
                  GAAP and therefore should not be considered an alternative to
                  net earnings as an indication of operating performance or to
                  net cash flow from operating activities as determined by GAAP
                  as a measure of liquidity and is not necessarily indicative of
                  cash available to fund cash needs.


                                       7






                             (In Thousands)

                                               March 31,      December 31,
                                                 2001             2000
                                                 ----             ----
                ASSETS
                                                           
Cash ....................................... $   6,906         $   5,364
Accounts Receivable - Net ..................    31,732            30,030
Other Current Assets .......................     4,560             5,098
                                                 -----             -----
  Total Current Assets .....................    43,198            40,492

Investment in leasehold ....................     1,617             1,679

Land and Buildings .........................   130,053           130,601
Less Accumulated Depreciation ..............   (17,638)          (17,680)
                                               -------           -------
Land and Buildings - Net ...................   112,415           112,921
                                               -------           -------

TOTAL ASSETS ............................... $ 157,230         $ 155,092
                                             =========         =========

              LIABILITIES
Accounts Payable ........................... $   8,995         $   8,636
Other Current Liabilities ..................     6,319             6,108
                                                 -----             -----
  Total Current Liabilities ................    15,314            14,744
                                                ------            ------

TOTAL LIABILITIES .......................... $  15,314         $  14,744
                                             =========         =========




Assets Held for Sale

     At March 31, 2001,  the carrying  value of assets held for sale totals $3.5
million (net of impairment  reserves of $7.8  million).  The Company  intends to
sell the remaining facilities as soon as practicable. However, a number of other
companies are actively  marketing  portfolios of similar assets and, in light of
the existing conditions in the long-term care industry generally,  it has become
more  difficult  to sell  such  properties  and for  potential  buyers to obtain
financing for such acquisitions. Thus, there can be no assurance if or when such
sales will be  completed  or whether  such sales will be completed on terms that
allow the Company to realize the fair value of the assets.


                                       8



Segment Information

     The following tables set forth the  reconciliation of operating results and
total assets for the Company's  reportable  segments for the three-month periods
ended March 31, 2001 and 2000.



                                                                              For the three months ended March 31, 2001
                                                                              -----------------------------------------

                                                                                    Owned and
                                                                                   Operated and
                                                                     Core          Assets Held           Corporate
                                                                  Operations         For Sale            and Other      Consolidated
                                                                  ----------         --------            ---------      ------------
                                                                                            (In Thousands)
                                                                                                               
Operating Revenues .............................................. $  21,699           $  45,997         $      -          $  67,696
Operating Expenses ..............................................         -             (46,450)               -            (46,450)
                                                                     ------             -------          -------            -------
  Net operating income ..........................................    21,699                (453)               -             21,246
Adjustments to arrive at net income:
  Other revenues ................................................         -                   -            1,481              1,481
  Interest expense ..............................................         -                   -           (9,672)            (9,672)
  Depreciation and amortization .................................    (4,324)               (996)            (221)            (5,541)
  General and administrative ....................................         -                   -           (2,349)            (2,349)
  Legal .........................................................         -                   -             (951)              (951)
  State Taxes ...................................................         -                   -             (106)              (106)
  Charges for derivative accounting .............................         -                   -             (482)              (482)
                                                                     ------                ----             ----               ----
                                                                     (4,324)               (996)         (12,300)           (17,620)
                                                                     ------                ----          -------            -------
Income (loss) before gain on assets sold and gain on
   early extinguishment of debt .................................    17,375              (1,449)         (12,300)             3,626
Gain on assets sold - net .......................................         -                 619                -                619
Gain on early extinguishment of debt ............................         -                   -              248                248
Preferred dividends .............................................         -                   -           (4,908)            (4,908)
                                                                     ------              ------           ------             ------
Net income (loss) available to common............................ $  17,375           $    (830)        $(16,960)         $    (415)
                                                                  =========           =========         ========          =========


Total Assets .................................................... $ 724,744           $ 160,777         $ 61,152          $ 946,673
                                                                  =========           =========         ========          =========



                                       9









                                                                              For the three months ended March 31, 2000
                                                                             -----------------------------------------

                                                                                     Owned and
                                                                                    Operated and
                                                                     Core            Assets Held        Corporate
                                                                  Operations          For Sale          and Other       Consolidated
                                                                  ----------          --------          ---------       ------------
                                                                                          (In Thousands)
                                                                                                                   
Operating Revenues ...............................................$  24,002           $  31,425        $       -        $   55,427
Operating Expenses ...............................................        -             (30,965)               -           (30,965)
                                                                     ------             -------          -------           -------
  Net operating income ...........................................   24,002                 460                -            24,462
Adjustments to arrive at net income:
  Other revenues .................................................        -                   -            1,787             1,787
  Interest expense ...............................................        -                   -          (11,098)          (11,098)
  Depreciation and amortization ..................................   (4,931)               (614)            (365)           (5,910)
  General and administrative .....................................        -                   -           (1,589)           (1,589)
  Legal ..........................................................        -                   -              (21)              (21)
  State Taxes ....................................................        -                   -             (113)             (113)
  Provision for impairment .......................................        -              (4,500)               -            (4,500)
                                                                      -----              ------           ------            ------
                                                                     (4,931)             (5,114)         (11,399)          (21,444)
                                                                     ------              ------          -------           -------

Earnings (loss)...................................................   19,071              (4,654)         (11,399)            3,018
Preferred dividends ..............................................        -                   -           (2,408)           (2,408)
                                                                     ------               -----           ------            ------
Net income (loss) available to common.............................$  19,071           $  (4,654)       $ (13,807)       $      610
                                                                  =========           =========        =========        ==========


Total Assets .....................................................$ 755,303           $ 168,207        $  97,639        $1,021,149
                                                                  =========           =========        =========        ==========





Note C - Concentration of Risk and Related Issues

     As of March 31,  2001,  the  Company's  portfolio  of domestic  investments
consisted of 261 healthcare facilities,  located in 29 states and operated by 28
third-party  operators.  The Company's  gross  investments  in these  facilities
totaled  $916.8  million at March 31,  2001.  This  portfolio  is made up of 130
long-term healthcare facilities and 2 rehabilitation  hospitals owned and leased
to third  parties,  fixed  rate,  participating  and  convertible  participating
mortgages  on 63 long-term  healthcare  facilities  and 66 long-term  healthcare
facilities that were recovered from customers and are currently operated through
third-party  management  contracts for the  Company's own account,  including 12
facilities subject to third-party  leasehold  interests.  The Company also holds
miscellaneous  investments  and closed  healthcare  facilities  held for sale of
approximately  $56.8 million at March 31, 2001,  including $22.3 million related
to two non-healthcare  facilities leased by the United States Postal Service, an
$8.3 million investment in Omega Worldwide,  Inc.,  Principal Healthcare Finance
Limited,  an Isle of Jersey (United  Kingdom)  company and Principal  Healthcare
Finance Trust, an Australian Unit Trust, and $15.5 million of notes receivable.

     Seven  public  companies  operate  approximately  76.1%  of  the  Company's
investments,  including Sun Healthcare Group,  Inc.  (26.2%),  Integrated Health
Services,  Inc.  (17.5%,  including  10.4% as the manager for Lyric  Health Care
LLC), Advocat, Inc. (11.6%),  Kindred Healthcare,  Inc.(formerly known as Vencor
Operating,   Inc.)  (5.8%),  Genesis  Health  Ventures,   Inc.  (5.3%),  Mariner
Post-Acute Network (6.0%) and Alterra Healthcare Corporation (3.7%). Kindred and



                                       10


Genesis  manage  facilities  for the Company's own account,  included in Owned &
Operated  Assets.  The two largest  private  operators  represent 3.4% and 3.2%,
respectively,  of  investments.  No other operator  represents more than 1.9% of
investments. The three states in which the Company has its highest concentration
of investments are Florida (15.5%), California (7.3%) and Illinois (7.2%).

Government Healthcare Regulation, Reimbursements and
    Industry Concentration Risks

     Nearly all of the Company's  properties are used as healthcare  facilities,
therefore,  the Company is directly  affected  by the risk  associated  with the
healthcare  industry.  The  Company's  lessees  and  mortgagors,  as well as the
facilities  owned and operated for the Company's  account,  derive a substantial
portion of their net operating revenues from third-party  payers,  including the
Medicare and Medicaid  programs.  Such programs are highly regulated and subject
to frequent and substantial  changes.  In addition,  private  payers,  including
managed care payers,  are increasingly  demanding  discounted fee structures and
the assumption by healthcare providers of all or a portion of the financial risk
of operating a healthcare facility.  Any changes in reimbursement policies which
reduce  reimbursement  levels could  adversely  affect revenues of the Company's
lessees and borrowers and thereby adversely affect those lessees' and borrowers'
abilities to make their monthly lease or debt payments to the Company.

     The  possibility  that the healthcare  facilities  will not generate income
sufficient  to meet  operating  expenses or will yield  returns lower than those
available through investments in comparable real estate or other investments are
additional  risks of investing in  healthcare-related  real estate.  Income from
properties  and yields from  investments  in such  properties may be affected by
many  factors,  including  changes in  governmental  regulation  (such as zoning
laws),  general or local economic  conditions  (such as fluctuations in interest
rates and  employment  conditions),  the  available  local supply and demand for
improved real estate, a reduction in rental income as the result of an inability
to maintain occupancy levels, natural disasters (such as earthquakes and floods)
or similar factors.

     Real estate  investments are relatively  illiquid and,  therefore,  tend to
limit the ability of the Company to vary its  portfolio  promptly in response to
changes in economic or other  conditions.  Thus,  if the operation of any of the
Company's   properties   becomes   unprofitable  due  to  competition,   age  of
improvements or other factors such that the lessee or borrower becomes unable to
meet its obligations on the lease or mortgage loan, the liquidation value of the
property may be substantially less, particularly relative to the amount owing on
any related  mortgage loan,  than would be the case if the property were readily
adaptable to other uses.

Potential Risks from Bankruptcies

     Generally,  the Company's  lease  arrangements  with a single  operator who
operates  more than one of the Company's  facilities  is designed  pursuant to a
single master lease (a "Master  Lease" or  collectively,  the "Master  Leases").
Although each lease or Master Lease  provides that the Company may terminate the
Master Lease upon the  bankruptcy or insolvency  of the tenant,  the  Bankruptcy
Reform Act of 1978  ("Bankruptcy  Code") provides that a trustee in a bankruptcy



                                       11


or reorganization  proceeding under the Bankruptcy Code (or debtor-in-possession
in a  reorganization  under the Bankruptcy Code) has the power and the option to
assume or reject the unexpired  lease  obligations  of a  debtor-lessee.  In the
event that the unexpired  lease is assumed on behalf of the  debtor-lessee,  all
the rental obligations thereunder generally would be entitled to a priority over
other unsecured claims.  However, the court also has the power to modify a lease
if  a  debtor-lessee  in a  reorganization  were  required  to  perform  certain
provisions of a lease that the court determined to be unduly  burdensome.  It is
not  possible at this time to  determine  whether or not a court would hold that
any lease or Master Lease contains any such provisions.  If a lease is rejected,
the lessor has a general  unsecured claim limited to any unpaid rent already due
plus an amount equal to the rent reserved under the lease, without acceleration,
for the greater of one year or 15% of the remaining  term of such lease,  not to
exceed the rent obligation for three years.

     Generally,  with respect to the Company's mortgage loans, the imposition of
an  automatic  stay  under  the  Bankruptcy  Code  precludes  the  Company  from
exercising foreclosure or other remedies against the debtor. A mortgagee also is
treated  differently from a landlord in three key respects.  First, the mortgage
loan is not subject to  assumption  or rejection  because it is not an executory
contract or a lease.  Second,  the  mortgagee's  loan may be divided  into (1) a
secured loan for the portion of the mortgage debt that does not exceed the value
of the property and (2) a general unsecured loan for the portion of the mortgage
debt that  exceeds the value of the  property.  A secured  creditor  such as the
Company is  entitled to the  recovery  of interest  and costs only if and to the
extent that the value of the collateral exceeds the amount owed. If the value of
the  collateral  is less than the debt,  a lender such as the Company  would not
receive or be entitled to any interest for the time period between the filing of
the case and confirmation.  If the value of the collateral does exceed the debt,
interest and allowed costs may not be paid during the bankruptcy  proceeding but
accrue until  confirmation of a plan or reorganization or some other time as the
court  orders.  Finally,  while a lease  generally  would  either be rejected or
assumed with all of its benefits  and burdens  intact,  the terms of a mortgage,
including the rate of interest and timing of principal payments, may be modified
if the debtor is able to effect a "cramdown" under the Bankruptcy Code.

     The receipt of liquidation  proceeds or the replacement of an operator that
has  defaulted on its lease or loan could be delayed by the approval  process of
any federal, state or local agency necessary for the transfer of the property or
the  replacement of the operator  licensed to manage the facility.  In addition,
certain significant expenditures associated with real estate investment (such as
real  estate  taxes and  maintenance  costs)  are  generally  not  reduced  when
circumstances  cause a  reduction  in income  from the  investment.  In order to
protect its  investments,  the Company may take possession of a property or even
become licensed as an operator,  which might expose the Company to successorship
liability to government programs or require the Company to indemnify  subsequent
operators to whom it might  transfer the operating  rights and  licenses.  Third
party  payors may also  suspend  payments to the Company  following  foreclosure
until the Company  receives  the  required  licenses to operate the  facilities.
Should such events occur,  the Company's  income and cash flows from  operations
would be adversely affected.


                                       12


Risks Related to Owned and Operated Assets

     As a consequence of the financial  difficulties  encountered by a number of
the  Company's  operators,  the Company has  recovered  various  long-term  care
assets,  pledged  as  collateral  for  the  operators'  obligations,  either  in
connection with a restructuring or settlement with certain operators or pursuant
to  foreclosure  proceedings.  Under  normal  circumstances,  the Company  would
classify such assets as "Assets Held for Sale" and seek to re-lease or otherwise
dispose  of such  assets  as  promptly  as  practicable.  However,  a number  of
companies are actively  marketing  portfolios of similar assets and, in light of
the current conditions in the long-term care industry  generally,  it has become
more difficult both to sell such  properties and for potential  buyers to obtain
financing  to acquire such  properties.  During  2000,  $24.3  million of assets
previously  classified as held for sale were reclassified to "Owned and Operated
Assets" as the timing and strategy for sale or, alternatively,  re-leasing, were
revised in light of prevailing market conditions.

     The  Company  is  typically  required  to  hold  applicable  leases  and is
responsible for the regulatory  compliance at its owned and operated facilities.
The  Company's  management   contracts  with  third-party   operators  for  such
properties  provide that the third-party  operator is responsible for regulatory
compliance,  but the Company  could be  sanctioned  for  violation of regulatory
requirements.  In addition,  the risk of third-party claims such as patient care
and  personal  injury  claims may be higher  with  respect to Company  owned and
operated properties as compared to the Company's leased and mortgaged assets.


Note D - Dividends

     On February 1, 2001, the Company announced the suspension of all common and
preferred dividends.  This action is intended to preserve cash to facilitate the
Company's  ability to obtain  financing to fund its 2002 maturing  indebtedness.
Prior to  recommencing  the payment of dividends on the Company's  Common stock,
all accrued and unpaid  dividends on the  Company's  Series A, B and C preferred
stock must be paid in full.  The Company has made  sufficient  distributions  to
satisfy the distribution  requirements under the REIT rules to maintain its REIT
status for 2000 and intends to satisfy  such  requirements  under the REIT rules
for 2001. The cumulative  unaccrued and unpaid dividends  relating to all series
of the  preferred  stock,  excluding  the  November  15, 2000 Series C dividends
described below, total $4.9 million as of March 31, 2001.

     On March 30,  2001,  the  Company  exercised  its option to pay the accrued
$4,666,667  Series C dividend from November 15, 2000 and the  associated  waiver
fee by issuing  48,420  Series C preferred  shares to Explorer on April 2, 2001,
which are convertible into 774,722 shares of the Company's common stock at $6.25
per share.  Such election  resulted in an increase in the aggregate  liquidation
preference of Series C Preferred Stock as of April 2, 2001 to $104,842,000.

     During  the  three-month  period  ended  March 31,  2000 the  Company  paid
dividends of $1.3 million and $1.1 million,  respectively, on its 9.25% Series A
Cumulative Preferred Stock and 8.625% Series B Cumulative Preferred Stock.


                                       13


Note E - Earnings Per Share

     The  computation  of basic  earnings per share is  determined  based on the
weighted  average  number of common  shares  outstanding  during the  respective
periods.  Diluted  earnings per share  reflect the dilutive  effect,  if any, of
stock  options  and,  beginning  in the  third  quarter  of  2000,  the  assumed
conversion of the Series C Preferred Stock. The conversion of the Company's 1996
convertible debentures is anti-dilutive and therefore not assumed.


Note F - Omega Worldwide, Inc.

     As of March 31, 2001 the Company  holds a $5.4 million  investment in Omega
Worldwide,  Inc. ("Worldwide"),  represented by 1,163,000 shares of common stock
and 260,000  shares of  preferred  stock.  The Company also holds a $1.6 million
investment in Principal  Healthcare  Finance Limited,  an Isle of Jersey (United
Kingdom) company,  and a $1.3 million investment in Principal Healthcare Finance
Trust,  an  Australian  Unit  Trust.  The Company has  guaranteed  repayment  of
Worldwide  borrowings pursuant to a revolving credit facility in exchange for an
initial 1% fee and an annual facility fee of 25 basis points.  At March 31, 2001
borrowings of $1,350,000 were  outstanding  under  Worldwide's  revolving credit
facility.  Worldwide's  credit agreement calls for scheduled payments to be made
until fully repaid in June 2001. Under this agreement, no further borrowings may
be made by  Worldwide  under its  revolving  credit  facility.  The  Company  is
required  to provide  collateral  in the amount of $8.8  million  related to the
guarantee  of  Worldwide's  obligations.  Upon  repayment  by  Worldwide  of the
remaining  outstanding balance under its revolving credit facility,  the subject
collateral  will be released in connection with the termination of the Company's
guarantee.

     Additionally,  the Company had a Services  Agreement  with  Worldwide  that
provided  for the  allocation  of  indirect  costs  incurred  by the  Company to
Worldwide.  The allocation of indirect costs has been based on the  relationship
of assets under the Company's  management to the combined  total of those assets
and assets under  Worldwide's  management.  Upon expiration of this agreement on
June 30, 2000,  the Company  entered into a new  agreement  requiring  quarterly
payments  from  Worldwide  of  $37,500  for  the  use  of  offices  and  certain
administrative  and  financial  services  provided  by  the  Company.  Upon  the
reduction  of  the  Company's   accounting  staff,  the  Service  Agreement  was
renegotiated  again on  November  1, 2000,  requiring  quarterly  payments  from
Worldwide of $32,500.  Costs allocated to Worldwide for the three-month  periods
ended March 31, 2001 and 2000 were $32,500 and $205,000, respectively.


Note G - Litigation

     The  Company  is subject to  various  legal  proceedings,  claims and other
actions arising out of the normal course of business. While any legal proceeding
or claim has an element of uncertainty,  management believes that the outcome of


                                       14


each lawsuit claim or legal proceeding that is pending or threatened,  or all of
them  combined,  will not have a  material  adverse  effect on its  consolidated
financial position or results of operations.

     On June 20,  2000,  the  Company  and its chief  executive  officer,  chief
financial  officer  and chief  operating  officer  were named as  defendants  in
certain litigation brought by Ronald M. Dickerman,  in his individual  capacity,
in the United States  District  Court for the Southern  District of New York. In
the complaint,  Mr. Dickerman  contends that the Company and the named executive
officers violated Section 10(b) and 20(a) of the Securities Exchange Act of 1934
and Rule 10b-5 promulgated  thereunder.  Mr. Dickerman  subsequently amended the
complaint to assert his claims on behalf of an unnamed class of  plaintiffs.  On
July 28, 2000,  Benjamin LeBorys commenced a class action lawsuit making similar
allegations against the Company and certain of its officers and directors in the
United States  District  Court for the Southern  District of New York. The cases
have been  consolidated,  and Mr.  LeBorys  has been named lead  plaintiff.  The
plaintiffs seek unspecified  damages. The Company has reported the litigation to
its  directors and officers  liability  insurer.  The Company  believes that the
litigation is without merit and is defending vigorously. The Company's Motion to
Dismiss  was filed with the Court on  February  16,  2001.  The  hearing on this
Motion is scheduled for May 23, 2001.

     On June  21,  2000,  the  Company  was  named  as a  defendant  in  certain
litigation  brought  against  it  by  Madison/OHI   Liquidity   Investors,   LLC
("Madison"),  a customer  that  claims  that the  Company  has  breached  and/or
anticipatorily  breached a commercial  contract.  Mr.  Dickerman is a partner of
Madison and is a guarantor of  Madison's  obligations  to the  Company.  Madison
claims  damages as a result of the  alleged  breach of  approximately  $700,000.
Madison  seeks  damages as a result of the  claimed  anticipatory  breach in the
amount of $15 million or, in the alternative, Madison seeks specific performance
of the  contract  as  modified  by a course  of  conduct  that  Madison  alleges
developed between Madison and the Company.  The Company contends that Madison is
in default  under the  contract  in  question.  The  Company  believes  that the
litigation is meritless.  The Company is defending vigorously and on December 5,
2000,  filed  counterclaims  against Madison and the  guarantors,  including Mr.
Dickerman, seeking repayment of approximately $8.5 million that Madison owes the
Company.

     Karrington Health,  Inc. brought suit against the Company alleging that the
Company  repudiated  and  ultimately  breached a  financing  contract to provide
$95,000,000 of financing for the development of 13 assisted  living  facilities.
Karrington seeks recovery of approximately  $20,000,000 in damages it alleges to
have incurred as a result of the breach. The Company denies that it entered into
a valid and binding  contract with  Karrington  and is vigorously  defending the
litigation.


Note H - Borrowing Arrangements

     The Company has a $175  million  secured  revolving  credit  facility  that
expires on December 31, 2002.  Borrowings  under the facility  bear  interest at
2.5% to 3.25% over LIBOR, based on the Company's  leverage ratio.  Borrowings of
approximately $127 million are outstanding at March 31, 2001. Investments with a
gross book value of  approximately  $240 million are pledged as  collateral  for
this credit facility.


                                       15


     The  Company has a $75  million  secured  revolving  credit  facility  that
expires on March 31, 2002 as to $10 million and June 30, 2005 as to $65 million.
Borrowings  under the facility bear interest at 2.5% to 3.75% over LIBOR,  based
on  the  Company's  leverage  ratio  and  collateral  assigned.   Borrowings  of
approximately $68.6 million are outstanding at March 31, 2001.  Investments with
a gross book value of  approximately  $90 million are pledged as collateral  for
this credit facility.

     During the quarter  ended March 31,  2001,  the  Company  repurchased  $2.0
million of its 6.95%  Notes  maturing  in June  2002.  At March 31,  2001,  $123
million of these notes remain outstanding.

     As of March 31,  2001,  the Company  had an  aggregate  of $259  million of
outstanding  debt which matures in 2002,  including  $123 million of 6.95% Notes
due June 2002 and $136 million on credit facilities expiring in 2002.

     The Company is  required to meet  certain  financial  covenants,  including
prescribed leverage and interest coverage ratios on its long-term borrowings.

     The  Company  has $50  million of funding  available  through  July 1, 2001
pursuant  to an  Investment  Agreement  with  Explorer  which can be used,  upon
satisfaction  of certain  conditions,  to fund growth.  Following the drawing in
full or expiration of this commitment,  Explorer will have the option to provide
up to an additional  $50 million to fund growth for an  additional  twelve-month
period. (See Note D - Dividends)


Note I - Effect of New Accounting Pronouncements

     The Company utilizes  interest rate swaps to fix interest rates on variable
rate debt and reduce certain  exposures to interest rate  fluctuations.  In June
1998,  the  Financial  Accounting  Standards  Board  issued  Statement  No. 133,
Accounting for Derivative Instruments and Hedging Activities,  which is required
to be adopted in years  beginning  after June 15, 2000. The Company  adopted the
new Statement  effective January 1, 2001. The Statement  requires the Company to
recognize all derivatives on the balance sheet at fair value.  Derivatives  that
are not hedges must be adjusted to fair value through income.  If the derivative
is a hedge,  depending on the nature of the hedge,  changes in the fair value of
derivatives will either be offset against the change in fair value of the hedged
assets, liabilities, or firm commitments through earnings or recognized in other
comprehensive  income  until the  hedge  item is  recognized  in  earnings.  The
ineffective  portion of a derivative's  change in fair value will be immediately
recognized in earnings.

     At March 31, 2001,  the Company had two interest  rate swaps with  notional
amounts of $32 million  each,  based on 30-day  London  Interbank  Offered Rates
(LIBOR). Under the terms of the first agreement, which expires in December 2001,
the Company receives payments when LIBOR exceeds 6.35% and pays the counterparty
when LIBOR is less than 6.35%. At March 31, 2001,  30-day Libor was 5.08 %. This


                                       16


interest rate swap may be extended for an additional twelve months at the option
of the  counterparty  and therefore does not qualify for hedge  accounting under
FASB No. 133. The fair value of this swap at January 1, and March 31, 2001 was a
liability of $351,344 and $745,138, respectively. The liability at January 1 was
recorded as a transition  adjustment in other comprehensive  income and is being
amortized  over the  initial  term of the swap.  Such  amortization  of $87,836,
together  with the change in fair value of the swap  during  the  quarter  ended
March 31, 2001 of $393,794 is included in charge for  derivative  accounting  in
the Company's Condensed Consolidated Statement of Operations.

     Under the second  agreement,  which expires  December 31, 2002, the Company
receives  payments when LIBOR exceeds 4.89% and pays the counterparty when LIBOR
is less than 4.89%.  The fair value of this interest rate swap at March 31, 2001
was a liability of $90,043,  which is included in other comprehensive  income as
required under FASB No. 133 for fully effective cash flow hedges.

     The fair  values of these  interest  rate  swaps are  included  in  accrued
expenses and other liabilities in the Company's Condensed  Consolidated  Balance
Sheet at March 31, 2001.


Note J - Subsequent Events

     As of April 2, 2001, the Company issued 48,420 Series C preferred shares to
Explorer,  which are  convertible  into 774,722  shares of the Company's  common
stock at $6.25 per share. (See Note D - Dividends.)

     In April,  2001 the Company was informed by TLC  Healthcare,  Inc.  ("TLC")
that it could no longer meet its payroll and other  operating  obligations.  The
Company had leases and mortgages with TLC  representing  eight  properties  with
1,049  beds and an  initial  investment  of $27.5  million.  As a result of this
action,  one facility in Texas with 102 beds and an initial  investment  of $2.5
million was leased to a new operator, Lamar Healthcare, Inc. and four properties
in  Illinois,  Indiana  and  Ohio,  with a  total  of 335  beds  and an  initial
investment  of $13.5  million,  were  taken  back and  placed  under  management
agreements  with Atrium Living  Centers and Nexion Health  Management,  Inc. and
will be operated  for the  Company's  own account  and  classified  as Owned and
Operated  Assets.  The  remaining  three  properties,  with a total  of 612 beds
located in Texas have either  been closed or are in the process of being  closed
and will be marketed for sale.

     In April,  2001 the Company  extended its forbearance  agreement with Lyric
Healthcare LLC ("Lyric") through May 31, 2001,  whereby the Company has received
$541,266 of the $860,000  monthly rent due under the Lyric  leases.  Discussions
are  continuing  with Lyric to reach a permanent  restructuring  agreement.  The
Company's  original  investment in the ten facilities covered under the lease is
$95.4 million, with annual rent of $10.3 million.


                                       17


     On  March  30,  2001  the  Company   announced  that  affiliates  of  Alden
Management,  Inc.  ("Alden")  were  delinquent  in paying their lease,  loan and
escrow  payments on the four  facilities it leases from the Company.  During the
month of April, Alden resumed regularly scheduled lease payments to the Company,
and began making payments on a schedule designed to bring their past due amounts
current by August of 2001.



                                       18



Item 2 -  Management's Discussion and Analysis of Financial Condition and
            Results of Operations.

"Safe Harbor" Statement Under the United States Private Securities
   Litigation Reform Act of 1995

     Certain  information  contained  in this report  includes  forward  looking
statements.   Forward  looking  statements  include  statements   regarding  the
Company's  expectations,   beliefs,   intentions,   plans,  objectives,   goals,
strategies,  future events or performance  and underlying  assumptions and other
statements  other than statements of historical  facts.  These statements may be
identified,  without limitation,  by the use of forward looking terminology such
as  "may"  "will"  "anticipates"  "expects"  "believes"  "intends"  "should"  or
comparable  terms  or the  negative  thereof.  All  forward  looking  statements
included  herein are based on  information  available on the date  hereof.  Such
statements  only speak as of the date  hereof and no  obligation  to update such
forward  looking  statements  should  be  assumed.  Actual  results  may  differ
materially from those  reflected in such forward looking  statements as a result
of a variety of factors,  including,  among other things: (i) the ability of the
Company to dispose of assets held for sale on a timely basis and at  appropriate
prices; (ii) uncertainties  relating to the operation of the Company's Owned and
Operated  Assets,  including  those  relating to  reimbursement  by  third-party
payors,  regulatory matters and occupancy levels;  (iii) the general distress of
the healthcare industry;  (iv) continued  deterioration of the operating results
and  financial  condition  of the  Company's  operators;  (v) the ability of the
Company's operators in bankruptcy to reject unexpired lease obligations,  modify
the terms of the Company's  mortgages,  and impede the ability of the Company to
collect unpaid rent or interest  during the pendency of a bankruptcy  proceeding
and retain security deposits for the debtor's obligations; (vi) the availability
and cost of  capital;  (vii)  regulatory  and other  changes  in the  healthcare
sector; (viii) the ability of the Company to manage , re-lease or sell its owned
and  operated  facilities;  (ix)  competition  in the  financing  of  healthcare
facilities;  (x) the effect of  economic  and market  conditions  and changes in
interest rates; (xi) the resumption of dividends;  (xii) the amount and yield of
any additional investments; (xiii) changes in tax laws and regulations affecting
real estate  investment  trusts;  access to the capital  markets and the cost of
capital (xiv) changes in the ratings of the Company's debt securities;  (xv) and
the risk factors set forth herein.

     Following  is a  discussion  of the  consolidated  results  of  operations,
financial  position and  liquidity and capital  resources of the Company,  which
should  be  read  in  conjunction  with  the  condensed  consolidated  financial
statements  and  accompanying  notes.  (See  Note  B - Properties  and  Note C -
Concentration of Risk and Related Issues.)

Results of Operations

     Revenues for the  three-month  period  ended March 31, 2001  totaled  $69.2
million,  an increase of $12.0  million  over the period  ending March 31, 2000.
This increase is  principally  due to the inclusion of revenue from nursing home
operations  for assets owned and operated for the  Company's  account  recovered
pursuant  to  foreclosure  and  settlements  with  troubled  operators  in 2000.
Excluding  nursing home  revenues of Owned and Operated  Assets,  revenues  were
$23.2  million for the  three-month  period  ended March 31, 2001, a decrease of
$2.6 million from the comparable prior year period.


                                       19


     Rental income for the three-month period ended March 31, 2001 totaled $16.0
million,  a decrease of $2.0 million over the same period in 2000.  The decrease
is due to $1.2 million from  reductions  in lease  revenue due to  foreclosures,
bankruptcies  and  restructurings,  and $1.1 million  from  reduced  investments
caused by 2000 asset sales.  These decreases are offset by $0.3 million relating
to contractual increases in rents that became effective in 2001 as defined under
the related agreements.

     Mortgage  interest income for the  three-month  period ended March 31, 2001
totaled $5.7 million,  decreasing $0.3 million from the same period in 2000. The
decrease  is  due  to  $0.4  million  from   reductions  due  to   foreclosures,
bankruptcies and restructurings and reduced investments caused by the payoffs of
mortgages  in 2000.  These  decreases  are offset by $0.1  million  relating  to
contractual  increases  in  interest  income that  became  effective  in 2001 as
defined under the related agreements.

     Nursing  home  revenues of owned and  operated  assets for the  three-month
period ended March 31, 2001 totaled $46.0 million, increasing $14.6 million over
the same period in 2000.  The increase is primarily  due to the  inclusion of 30
facilities formerly operated by RainTree Healthcare Corporation ("RainTree") for
the full  three-month  period  ended March 31, 2001 versus one month  during the
three-month period ended March 31, 2000.

     Expenses for the  three-month  period  ended March 31, 2001  totaled  $65.6
million,  increasing  approximately $11.4 million over expenses of $54.2 million
for the three-month period ended March 31, 2000.

     Nursing home  expenses for owned and  operated  assets for the  three-month
period ended March 31, 2001  increased to $46.5  million from $31.0  million for
the  three-month  period ended March 31, 2000.  The increase is primarily due to
the  inclusion  of 30  facilities  formerly  operated by  RainTree  for the full
three-month  period ended March 31, 2001 versus one month during the three-month
period ended March 31, 2000.

     Interest  expense  for the  three-month  period  ended  March 31,  2001 was
approximately  $9.7 million,  compared with $11.1 million for the same period in
2000.  The  decrease  in 2001 is  primarily  due to  lower  average  outstanding
borrowings  during the 2001 period,  partially offset by higher average interest
rates.

     The provision for depreciation and amortization of real estate totaled $5.5
million during the  three-months  ended March 31, 2001,  decreasing $0.4 million
over the same period in 2000.  The decrease  primarily  consists of $0.2 million
due to assets sold in 2000 and capital  expenditures  and impairment  charges on
owned and operated  properties,  and a reduction in amortization of goodwill and
non-compete agreements of $0.2 million.


                                       20


     General and administrative  expenses for the three-month period ended March
31, 2001 totaled $2.3 million as compared to $1.6 million for the same period in
2000,  an  increase  of  $0.7  million.  The  increase  is  due in  part  to the
incremental  administrative  costs  incurred  to manage  the owned and  operated
assets and increased consulting costs related to the foreclosure assets.

     Legal expenses for the three-month period ended March 31, 2001 totaled $1.0
million,  an increase of $0.9 million over the same period in 2000. The increase
is largely  attributable to legal costs associated with the operator  bankruptcy
filings and negotiations with the Company's troubled operators.

     A provision for  impairment of $4.5 million is included in expenses for the
three-month  period ended March 31, 2000.  This  provision  was to reduce assets
held for sale to fair value less cost to dispose.  No provision  for  impairment
was recognized in the 2001 period.

     During the three-month  period ended March 31, 2001, the Company recognized
a gain on disposal of real estate of $0.6 million.

     Funds from operations (FFO) for the three-month period ended March 31, 2001
on a fully diluted basis totaled $6.8 million,  a decrease of approximately $5.3
million as  compared  to the $12.1  million  for the same  period in 2000 due to
factors mentioned above. FFO is net earnings  available to common  shareholders,
excluding any gains or losses from debt  restructuring  and the effects of asset
dispositions,  plus  depreciation and  amortization  associated with real estate
investments.  The Company  considers FFO to be one performance  measure which is
helpful to investors  of real estate  companies  because,  along with cash flows
from operating  activities,  financing activities and investing  activities,  it
provides  investors and understanding of the ability of the Company to incur and
service debt and to make  expenditures.  FFO in and of itself does not represent
cash generated from operating  activities in accordance  with GAAP and therefore
should not be  considered  an  alternative  to net earnings as an  indication of
operating  performance  or  to  net  cash  flow  from  operating  activities  as
determined by GAAP as a measure of liquidity and is not  necessarily  indicative
of cash available to fund cash needs.

     No  provision  for  Federal  income  taxes has been made since the  Company
continues to qualify as a real estate  investment  trust under the provisions of
Sections  856  through 860 of the  Internal  Revenue  Code of 1986,  as amended.
Accordingly, the Company has not been subject to Federal income taxes on amounts
distributed to shareholders, as it distributed at least 95% (90% in 2001) of its
real  estate   investment  trust  taxable  income  and  has  met  certain  other
conditions.


Liquidity and Capital Resources

     At March  31,  2001  the  Company  had  total  assets  of  $946.7  million,
shareholders'  equity of $468.5  million,  and long-term debt of $442.6 million,
representing  approximately  46.8%  of total  capitalization.  The  Company  has
revolving credit facilities in place, providing up to $250 million of financing,
of which  $195.6  million was drawn at March 31,  2001,  leaving  $54.4  million
available for working capital and acquisition purposes.



                                       21


     As of March 31,  2001,  the Company  had an  aggregate  of $308  million of
outstanding  debt which matures in 2002,  including  $123 million of 6.95% Notes
due June 2002 and $185 million on credit facilities expiring in 2002.

     The  Company  has $50  million of funding  available  through  July 1, 2001
pursuant to an Investment  Agreement with Explorer Holdings,  L.P.  ("Explorer")
which can be used,  upon  satisfaction  of certain  conditions,  to fund growth.
Following the drawing in full or expiration  of this  commitment,  Explorer will
have the option to provide up to an additional $50 million to fund growth for an
additional twelve-month period.

     The Company has historically distributed to shareholders a large portion of
the cash available from operations.  The Company's historical policy has been to
make  distributions on Common Stock of approximately  80% of FFO. Cash dividends
paid totaled $0.50 per common share for the  three-month  period ended March 31,
2000. No common dividends were paid during the first quarter of 2001.

     On February 1, 2001, the Company announced the suspension of all common and
preferred dividends.  This action is intended to preserve cash to facilitate the
Company's  ability  to  obtain  financing  to fund  the  2002  debt  maturities.
Additionally,  on March 30, 2001,  the Company  exercised  its option to pay the
accrued  $4,666,667  Series C dividend from November 15, 2000 and the associated
waiver fee by issuing  48,420 Series C preferred  shares to Explorer on April 2,
2001, which are convertible into 774,722 shares of the Company's common stock at
$6.25 per share.

     The Company  anticipates that it will reinstate dividends on its common and
preferred stock when the Company determines that it has sufficient  resources or
satisfactory plans to meet its 2002 debt maturities, but the Company can give no
assurance  as to when the  dividends  will be  reinstated  or the  amount of the
dividends if and when such payments are  recommenced.  Prior to recommencing the
payment of  dividends  on the  Company's  Common  stock,  all accrued and unpaid
dividends  on the  Company's  Series A, B and C Preferred  Stock must be paid in
full. The Company has made sufficient  distributions to satisfy the distribution
requirements  under the REIT  rules to  maintain  its REIT  status  for 2000 and
intends to satisfy such requirements under the REIT rules for 2001.

     Management   believes  the  Company's  liquidity  and  various  sources  of
available  capital  are  adequate  to  finance  operations,  meet  debt  service
requirements  and fund  future  investments  through  the next 12 months  but is
taking  immediate  steps to secure a  refinancing  of such debt,  including  the
announced  suspension  of  dividends  and the  pursuit  of capital  sources  for
repayment or replacement of the 2002 debt maturities. As a result of the ongoing
financial  challenges  facing long-term care operators,  the availability of the
external capital sources  historically  used by the Company has become extremely
limited  and  expensive,  and,  therefore,  no  assurance  can be given that the
Company will be able to replace or extend the 2002 debt maturities,  or that any
refinancing or replacement financing would be on favorable terms to the Company.



                                       22


If the Company is unable to obtain refinancing or replacement financing,  it may
be required to liquidate investments in properties at times which may not permit
realization of the maximum recovery on such investments.  This could also result
in adverse tax consequences to the Company.



                                       23



Item 3 - Quantitative and Qualitative Disclosure About Market Risk

     The Company is exposed to various  market  risks,  including  the potential
loss arising from adverse changes in interest rates.  The Company does not enter
into  derivatives  or other  financial  instruments  for trading or  speculative
purposes,  but the Company  seeks to mitigate  the  effects of  fluctuations  in
interest rates by matching the term of new investments  with new long-term fixed
rate borrowing to the extent possible.

     The market  value of the  Company's  long-term  fixed rate  borrowings  and
mortgages  are subject to interest  rate risk.  Generally,  the market  value of
fixed rate  financial  instruments  will  decrease  as  interest  rates rise and
increase as interest rates fall. The estimated fair value of the Company's total
long-term  borrowings at March 31, 2001 was $408 million. A one percent increase
in  interest  rates would  result in a decrease  in the fair value of  long-term
borrowings by approximately $5.5 million.

     The Company is subject to risks  associated  with debt or preferred  equity
financing,  including the risk that existing  indebtedness may not be refinanced
or that the terms of such  refinancing  may not be as  favorable as the terms of
current  indebtedness.  If the Company  were unable to  refinance  its 2002 debt
maturities  or other  indebtedness  on acceptable  terms,  it might be forced to
dispose of properties on disadvantageous  terms, which might result in losses to
the Company and might  adversely  affect the cash available for  distribution to
shareholders, or to pursue dilutive equity financing. If interest rates or other
factors  at the time of the  refinancing  result in higher  interest  rates upon
refinancing,  the Company's interest expense would increase,  which might affect
the Company's ability to make distributions to its shareholders.

     The Company utilizes  interest rate swaps to fix interest rates on variable
rate debt and reduce certain exposures to interest rate  fluctuations.  At March
31, 2001,  the Company had two interest rate swaps with notional  amounts of $32
million each, based on 30-day London Interbank Offered Rates (LIBOR).  Under the
first $32 million  agreement,  the Company receives payments when LIBOR interest
rates exceed 6.35% and pays the counterparties when LIBOR rates are under 6.35%.
The  amounts  exchanged  are  based on the  notional  amounts.  The $32  million
agreement  expires in December,  2001 but may be extended for an additional year
by the counterparty.

     Under the terms of the second agreement,  which expires in December,  2002,
the  Company  receives  payments  when  LIBOR  rates  exceed  4.89% and pays the
counterparties  when LIBOR rates are under 4.89%. The combined fair value of the
interest  rate swaps at March 31, 2001 was a deficit of  $835,000. (See Note I -
Effect of New Accounting Pronouncements.)




                                       24



PART II - OTHER INFORMATION

Item 2.           Changes in Securities and Use of Proceeds.


On  March  30,  2001,  the  Company  exercised  its  option  to pay the  accrued
$4,666,667  Series C dividend from November 15, 2000 and the  associated  waiver
fee by issuing  48,420  Series C preferred  shares to Explorer on April 2, 2001,
which are convertible into 774,722 shares of the Company's common stock at $6.25
per share.

The shares of Series C Preferred are governed by the Articles  Supplementary for
Series C Convertible  Preferred Stock (the "Articles  Supplementary") filed with
the State  Department of Assessments  and Taxation of Maryland on July 14, 2000.
The shares of Series C Preferred  were  issued  without  registration  under the
Securities Act of 1933, as amended (the  "Securities  Act") because the issuance
did not  involve a sale  within  the  meaning of  the  Securities  Act and/or in
reliance upon the private  placement  exemption  provided by Section 4(2) of the
Securities Act.



                                       25



Item 6.           Exhibits and Reports on Form 8-K

       (a)      Exhibits - There are no exhibits filed herewith.

       (b)      Reports on Form 8-K - none were filed.



                                       26




                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                                OMEGA HEALTHCARE INVESTORS, INC.
                                                          Registrant


Date:   May 15, 2001                  By:  /s/  Thomas W. Erickson
                                                ------------------
                                                Thomas W. Erickson
                                                Interim Chief Executive Officer

Date:   May 15, 2001                  By:  /s/  Richard M. FitzPatrick
                                                ----------------------
                                                Richard M. FitzPatrick
                                                Acting Chief Financial Officer




                                       27